vimarsana.com
Home
Live Updates
Exagen Inc. Collaboration Leads to Characterization of : vim
Exagen Inc. Collaboration Leads to Characterization of : vim
Exagen Inc. Collaboration Leads to Characterization of
SAN DIEGO, Sept. 01, 2022 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, announced today that its...
Related Keywords
,
Ron Rocca ,
Kamal Adawi ,
Mathew Woodruff ,
Ryan Douglas ,
Exchange Commission ,
Emory School Of Medicine ,
Emory University ,
Sanz At Emory University ,
Lowance Center ,
Exagen Inc ,
Nasdaq ,
Cell Bound Complement Activation Products ,
Human Immunology ,
Emory School ,
San Diego County ,
Annual Report ,
Private Securities Litigation Reform Act ,
Chief Financial ,
Nasdaq Xgn ,
Sign ,
Exagen ,
Memory ,
Covid ,
Autoimmune Disease ,
Vise Ctd ,